
Beacon Biosignals is an AI-driven neurotechnology company focused on accelerating drug development for neurological and psychiatric conditions. Their end-to-end platform utilizes FDA-cleared EEG headbands and AI-powered analytics to collect and analyze brain data, providing novel biomarkers for clinical trials. The platform includes the Waveband EEG headband for data collection, the Beacon Datastore for data storage and analysis, Beacon HQ for trial management, and comprehensive Clinical Study Operations and Scientific Services. Beacon aims to improve trial accuracy, patient stratification, and support expanded labeling claims for new treatments, ultimately getting life-changing therapies to patients faster. Their technology supports translational research, clinical trial optimization, and clinical practice by extracting meaningful insights from EEG data.

Beacon Biosignals is an AI-driven neurotechnology company focused on accelerating drug development for neurological and psychiatric conditions. Their end-to-end platform utilizes FDA-cleared EEG headbands and AI-powered analytics to collect and analyze brain data, providing novel biomarkers for clinical trials. The platform includes the Waveband EEG headband for data collection, the Beacon Datastore for data storage and analysis, Beacon HQ for trial management, and comprehensive Clinical Study Operations and Scientific Services. Beacon aims to improve trial accuracy, patient stratification, and support expanded labeling claims for new treatments, ultimately getting life-changing therapies to patients faster. Their technology supports translational research, clinical trial optimization, and clinical practice by extracting meaningful insights from EEG data.
Headquarters / Focus: Boston-based neurotechnology company building AI-driven EEG analytics and at-home EEG hardware
Product: End-to-end platform (Waveband EEG headband, cloud analytics, trial management, clinical services)
Regulatory: FDA 510(k) clearances for SleepStageML and at-home headband (marketed as Waveband)
Founded: 2019
Funding (total): Over $121M (Series B announced Nov 13, 2025)
Drug development, clinical trials, diagnostics, and translational neurophysiology focused on neurological, psychiatric, and sleep disorders.
2019
Software Development
$86,000,000
Announced Series B bringing total funding to more than $121M; syndicate included Innoviva, Google Ventures (GV), Nexus NeuroTech Ventures, S32, Catalio Capital Management, and Takeda
General Catalyst reported as Series A lead investor; other reported investors across rounds include Indicator Ventures, Casdin Capital, and Andrew Beck
“Multiple venture and strategic investors including General Catalyst, Google Ventures, Casdin Capital, Innoviva, and Takeda”
| Company |
|---|
Beacon Dx is on a mission to transform clinical diagnostics for sleep and brain health. We are building the leading home-based platform for precision diagnostics, combining EEG and cardiopulmonary signals to deliver comprehensive, reimbursable assessments for sleep and central nervous system disorders. Our solution integrates multi-channel physiological data—including airflow, respiratory effort, oxygen saturation, and brain activity—into a single streamlined workflow powered by AI-enabled analytics. With a dedication to patient experience and a foundation in FDA 510(k)-cleared technology, Beacon Dx enables high-quality diagnostics at scale. We are redefining how patients are evaluated and managed for conditions that affect brain and sleep physiology—bringing clinical-grade insights directly to the home.
Beacon Dx is seeking a results-driven and mission-oriented to accelerate growth and expand our market presence in the home sleep testing industry. In this role, the candidate will be instrumental in expanding access to at-home diagnostic care by creating new business opportunities, managing strategic customer accounts, and building strong partnerships with key stakeholders. The successful candidate will lead initiatives to identify and cultivate leads, deliver high-impact product demonstrations and negotiate agreements all while upholding Beacon’s commitment to clinical excellence and high level of customer satisfaction. This position is based in the East Coast region of the United States and will report to the President, Diagnostics.
What Success Looks Like
What You Will Bring
The base salary range for this role is determined based on past experience, specific skills and qualifications. The base salary is one component of the total compensation package, which includes equity, PTO and other benefits.
At Beacon, we've found that cultural and scientific impact is driven most by those that lead by example. As such, we're always seeking new contributors whose work demonstrates an avid curiosity, a bias towards simplicity, an eye for composability, a self-service mindset, and - most of all - a deep empathy towards colleagues, stakeholders, users, and patients. We believe a diverse team builds more robust systems and achieves higher impact.